- Home
- OMH vs CING Comparison
OMH vs CING Comparison
Compare OMH & CING Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OMH
- CING
- Stock Information
- Founded
- OMH 2015
- CING 2012
- Country
- OMH Singapore
- CING United States
- Employees
- OMH N/A
- CING N/A
- Industry
- OMH Real Estate
- CING Biotechnology: Pharmaceutical Preparations
- Sector
- OMH Finance
- CING Health Care
- Exchange
- OMH Nasdaq
- CING Nasdaq
- Market Cap
- OMH 13.6M
- CING 16.2M
- IPO Year
- OMH 2023
- CING 2021
- Fundamental
- Price
- OMH $0.60
- CING $4.36
- Analyst Decision
- OMH Strong Buy
- CING Strong Buy
- Analyst Count
- OMH 1
- CING 4
- Target Price
- OMH $15.00
- CING $30.67
- AVG Volume (30 Days)
- OMH 543.7K
- CING 250.6K
- Earning Date
- OMH 06-26-2025
- CING 05-08-2025
- Dividend Yield
- OMH N/A
- CING N/A
- EPS Growth
- OMH N/A
- CING N/A
- EPS
- OMH N/A
- CING N/A
- Revenue
- OMH $7,976,578.00
- CING N/A
- Revenue This Year
- OMH $28.40
- CING N/A
- Revenue Next Year
- OMH $21.08
- CING N/A
- P/E Ratio
- OMH N/A
- CING N/A
- Revenue Growth
- OMH 117.53
- CING N/A
- 52 Week Low
- OMH $0.60
- CING $1.80
- 52 Week High
- OMH $6.20
- CING $20.83
- Technical
- Relative Strength Index (RSI)
- OMH 27.02
- CING 61.94
- Support Level
- OMH $1.90
- CING $3.81
- Resistance Level
- OMH $2.14
- CING $4.09
- Average True Range (ATR)
- OMH 0.32
- CING 0.26
- MACD
- OMH -0.15
- CING 0.07
- Stochastic Oscillator
- OMH 0.89
- CING 96.43
About OMH Ohmyhome Limited
Ohmyhome Ltd is a data and technology-driven property technology company based in Singapore. Through its subsidiaries, it operates a one-stop-shop property platform that provides end-to-end property solutions and services for its customers, which comprises brokerage services and emerging and other services, such as home renovation and furnishing services, listing and research, mortgage referral, legal services, and insurance referral services. The company derives its revenues from two sources: revenue from brokerage services, property management services, and revenue from emerging and other services.
About CING Cingulate Inc.
Cingulate Inc is a clinical-stage biopharmaceutical company utilizing its proprietary precision timed-release drug delivery platform to build and advance a pipeline of next-generation pharmaceutical products designed to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes. The company focuses on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD) and anxiety, and identifying and evaluating additional therapeutic area to use PTR technology to develop future product candidates.